COMMITTEE ENGAGEMENT AND STAKEHOLDERS

GOVERNMENT, HEALTH AND PROFESSIONAL RELATIONSHIPS

VCS Foundation strongly values its working relationships with our partners, which include: Government Departments both State and Commonwealth, Cancer Councils, medical colleges, universities, major teaching hospitals, sexual and reproductive health services, primary care and community organisations, and technology and device service providers. VCS Foundation is a key contributor to state, national and international cervical cancer control policy and initiatives. VCS Foundation staff continue to serve in-kind on expert advisory committees and participate in working groups and forums that support both the Commonwealth and Victorian Governments in relation to cancer, cancer screening and immunisation. This includes committees responsible for the success of the renewed National Cervical Screening Program (NCSP) and international committees.

COMMITTEE ENGAGEMENT

COMMITTEE

INTERNATIONAL

International Taskforce on Cervical Cancer Elimination in The Commonwealth. March 2021

International Papillomavirus Society Policy Committee New Zealand Technical Reference Group - HPV Testing for Primary Screening Project Non-trials workgroup, One dose HPV vaccine consortium (PI PATH, Funding Bill and Melinda Gates Foundation) - Member and external advisor

WHO Elimination Data Monitoring Group WHO Director-General’s Expert Advisory Group on the Elimination of Cervical Cancer

Member of the Program Committee and Faculty for Eurogin 2021 meeting, Dusseldorf, Germany VCS STAFF MEMBER PURPOSE/CONTRIBUTION

Prof Marion Saville Australian-led resolution by member states of the World Health Organization (WHO): Cervical Cancer Prevention and Control: Accelerating the Elimination of Cervical Cancer as a Public Health Problem. Australia stands ready to work with the international community to take these commitments forward. Prof Julia Brotherton Engagement with lead policy makers in HPV and cervical screening.

Prof Marion Saville (Chair) Close ongoing connections with NZ Ministry of Health in relation to transition to HPV primary screening.

Prof Julia Brotherton Close ongoing connections with international HPV immunisation experts relating to ongoing research and evaluation of HPV vaccine impact.

Prof Marion Saville Direct engagement with international groups regarding best practice for program monitoring. Prof Julia Brotherton Direct engagement with lead international group strategy setting for global cervical cancer elimination.

Prof Julia Brotherton Since its creation three decades ago, the EUROGIN congress has gained a strong reputation as one of the leading international conferences on HPV infection and associated cancers. The meeting offers a forum for high-level scientific exchange involving multiple disciplines, with the aim to translate research into clinical practice.

COMMITTEE

INTERNATIONAL VCS STAFF MEMBER PURPOSE/CONTRIBUTION

Rapporteur and technical writer, Strategic Advisory Group of Experts HPV Working Party 2021-2022, World Health Organization, Geneva Chair, Data Monitoring and Safety Board, ADDVAC study Prof Julia Brotherton Supporting the work of the global expert committee providing advice on use of HPV vaccines.

Prof Julia Brotherton Study assessing The Population-Level Impact of Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania: A Cluster-Randomised Trial. Study Sponsor London School of Hygiene & Tropical Medicine (CIA D Watson Jones).

Invited Council Member, HPV Vaccine Council, CHIC

Member of the IPVC 2021 Public Health Workshop Committee Prof Julia Brotherton The Council is a global forum of experts intended to foster efficient translation of implementation research to guide practice and more equitable access to immunization and is part of the Bill and Melinda Gates Foundation funded Coalition to Strengthen the HPV Immunization Community (CHIC) project. Prof Julia Brotherton Supporting public health stream of the leading international HPV conference.

International Agency for Research on Cancer (IARC) Working Group for Handbook 18 on Cervical Screening 2020 Member of the International Collaboration on Cancer Reporting (ICCR) Expert Committee working on the 4th edition cervix cancer dataset

Host of the ISGyP LiVE team’s monthly online Journal Club Prof Julia Brotherton IARC prepares and distributes authoritative information on the causes and prevention of cancer throughout the world.

Dr Karen Talia Information obtained through membership of this Committee is communicated to VCS Pathologists, ensuring that our reporting of cervical biopsies and excision specimens is in line with world's best practice. This is reflected in our recent updating of the histology reporting codes. Dr Karen Talia Mentor trainees and early career pathologists (including VCS Pathologists) in critically evaluating and presenting journal articles.

Chair of Digital pathology meeting and co-chair of pathology education meeting. International Academy of Pathology (IAP) – Australasian Division Dr Kais Kasem Organise and deliver annual program at the IAP conference for both meetings.

NATIONAL Chair, Working Group, National Cervical Screening Program, Guidelines Prof Marion Saville Guide the working party in terms of task (developing the guideline) and process (how the group works). Assist the working party to work collaboratively, ensuring a balanced contribution from all members.

17th National Immunisation Conference 2021 - Conference Advisory Committee

Australian Government Department of Health: National Cervical Screening Program “Clinical Expert Panel” Prof Julia Brotherton Close ongoing connections with Australia’s immunisation experts and community relating to ongoing research and evaluation of HPV vaccine impact which has direct implications for HPV based screening performance i.e. assists in setting future direction of the NCSP. Prof Marion Saville Provision of clinical expertise to the Federal Government as required.

Australian Government Department of Health: National Cervical Screening Program “Self-Collection Expert Advisory Group” Prof Marion Saville Supports self-collection policy development and adoption in never and under screened Australian women. Was formerly the Working Group.

National Pathology Accreditation Advisory Council (NPAAC) “Standards Cervical Screening Drafting Committee” Prof Marion Saville A/Prof David Hawkes Directly supports Australian laboratory standards for pathology laboratories reporting cervical screening tests.

COMMITTEE ENGAGEMENT

COMMITTEE

NATIONAL

National Quality Safety Monitoring Committee

Horizon Scanning Working Group, a subcommittee of the NCSP Quality and safety monitoring group. RCPA QAP Cytopathology Advisory Committee

RCPA QAP Molecular Infectious Diseases VCS STAFF MEMBER PURPOSE/CONTRIBUTION

A/Prof David Hawkes Peak committee governing the NCSP quality framework. Includes best practices for data management and reporting. Prof Marion Saville Networking with advocates and experts in the HIV and sexual health community and providing technical advice in relation to the spectrum of HPV related diseases, screening and vaccination.

Prof Marion Saville

Grace Tan

Directly assists the performance monitoring of laboratories reporting services under the NCSP. VCS Foundation provides feedback and support as committee members. This extends to facilitating a “dummy run” with the RCPA QAP to test data entry processes from a lab perspective using ‘Gotomeeting’. A/Prof David Hawkes Technical advice supporting the quality and testing framework for HPV testing.

National Cervical Screening Program Data Dictionary Working Group

HPV Evaluation Advisory Committee, National Centre for Immunisation Research and Surveillance Prof Marion Saville Genevieve Chappell Karen Peasley

Assist the Australian Institute of Health and Welfare (AIHW) in the review of the National Cervical Screening Program (NCSP) Data Dictionary Version 1.0 in light of changes to clinical management guidelines, the program or data. This will include the review of data items, performance indicator specifications and coding sheets. Prof Julia Brotherton Providing input, advice and technical support to a national evaluation of the HPV vaccination program.

RCPA Microbiology Examiner Dr Hui Tat Mark Chan Contributing to ensure Clinical microbiologists in training meet adequate standards to practise as independent professionals.

National Cancer Screening Register Cervical Reporting User Forum Member Karen Peasley Genevieve Chappell The purpose of this group is to enable information sharing and operational discussion regarding issues and insights related to the National Cancer Screening Register (NCSR) reporting services in relation to the National Cervical Screening Program (NCSP).

Public Pathology Australia Communications Team Kate Wilkinson This is a working group comprised of communications staff from Public Pathology Australia member organisations. Its purpose is to collaborate on communications campaigns and strategies to increase community and government awareness of the value of public pathology services in supporting Australian’s health.

Member RCPA Anatomical pathology advisory committee

Dr Kais Kasem Established to provide expert advice to the Board of Directors regarding training and identification of areas of concern or new initiatives which require review from a political perspective. Member RCPA Academic committee Dr Kais Kasem Provide advice on promotion of pathology and develop opportunities in academic pathology at the levels of University education, junior doctors and Registrars.

STATE Cancer Council NSW, Scientific Advisory Committee for cervical stream of ‘Pathways to a Cancerfree future’ Prof Julia Brotherton Prof Marion Saville Assists in setting future direction of the National Cervical Screening Program.

Cancer Council Victoria – Self-collection Roll Out Committee Prof Marion Saville Benefits to National Cervical Screening Program in self-collection and promoting participation in under-never screened women. Assists NCSP implementation and achievement of outcomes.

COMMITTEE ENGAGEMENT

COMMITTEE

STATE VCS STAFF MEMBER PURPOSE/CONTRIBUTION

Victorian Department of Health Victorian Cancer Screening Steering Committee Prof Marion Saville The committee provides guidance to support Victoria’s delivery of and investment in cancer screening programs and facilitates collaboration across screening programs to maximise efficiencies and reduce duplication. VCS Foundation provides expertise to support strategic screening priorities including participation and recruitment, data and reporting, research and evaluation and health workforce education.

Victorian Cancer Screening Data and Surveillance Working Group (auspiced by Department of Health Vic)

Victorian Cancer Screening Evaluation and Research Working Group [auspiced by Department of Health Vic]

Victorian Cancer Screening Primary Care and Workforce Working Group (auspiced by Department of Health Vic)

Medical Laboratory Quality Network Committee

Steering Committee, Cancer Council Victoria’s Eliminate Cervical Cancer Fund 2020 Genevieve Chappell (Chair) Karen Peasley John Siddham

Chaired by VCS Foundation, this group is responsible for developing and implementing the Cancer Screening Data and Surveillance Strategy 2019-2022. The strategy aims to improve surveillance of the effectiveness and outcomes of the breast, bowel and cervical screening programs in Victoria through an integrated and consistent approach to data collection, use and reporting. Cervical screening data produced will inform Victorian initiatives to improve under and never-screened women’s participation, and support cervical screening research and education activities. Prof Julia Brotherton This group provides a forum for cancer screening partners and the Department of Health to work together to develop an Evaluation Strategy to monitor the delivery and outcomes of the Victorian Cancer Screening Framework, agree on strategic research priorities for cancer screening programs in Victoria, and enable a coordinated and collaborative approach to sharing research, evidence and best practice in cancer screening.

Prof Marion Saville Kate Wilkinson Kim Lee

Chaired by VCS Foundation, this group is responsible for developing and implementing the Cancer Screening Primary Care and Workforce Strategy 2019-2022. The Strategy will support an integrated, evidence-based cancer screening education and training approach and supporting systems, resources, tools and communications for the cancer screening workforce to improve adherence to clinical guidelines, increase health care practitioner endorsement of screening, and increase participation of underscreened populations. A/Prof David Hawkes Victorian peer organisation for the development and application of quality frameworks within public laboratories.

Prof Julia Brotherton Prof Marion Saville Providing expertise to progress Victorian Government’s commitment to eliminate cervical cancer. The four-year plan tabled aligns with Cancer Council Victoria’s objective to eliminate cervical cancer by 2030 – possibly becoming the first jurisdiction in Australia to do so.

Victorian Government COVID-19 Laboratory Liaison Group

BSV Data Hub Project Board Member

HPV Working Group, Positive Life, NSW Dr Kais Kasem Established to provide expert advice to the Board of Directors regarding training and identification of areas of concern or new initiatives which require review from a political perspective. Genevieve Chappell Group responsible for overseeing work to facilitate the transfer of BreastScreen Victoria (BSV) data to VCS Foundation for data and reporting purposes under the Victorian Cancer Screening Framework. The project will establish a data hub to enable ongoing transfer of BSV datasets to VCS Foundation and other external reporting agencies. Prof Julia Brotherton Networking with advocates and experts in the HIV and sexual health community and providing technical advice in relation to the spectrum of HPV related diseases, screening and vaccination.

COMMITTEE ENGAGEMENT AND STAKEHOLDERS

STRATEGIC PARTNERSHIPS

PARTNER Cancer Council New South Wales Cancer Council Victoria Victorian Aboriginal Community Controlled Health Organisation Inc. Clinicians and Nurse Pap Smear Providers Royal Women’s Hospital Public Pathology Australia University of Melbourne University of Sydney Kirby Institute – University of New South Wales National Centre for Immunisation Research and Surveillance (NCIRS) Menzies School of Health Research Australian National University University of Malaya Public Health Association of Australia Global Health Alliance PROJECT Compass Trial, Research Supporting the National Cervical Screening Program in Victoria

Supporting the National Cervical Screening Program in Victoria

Supporting the National Cervical Screening Program in Victoria VCS Foundation Tenancy (Carlton) and Research National collaborative laboratory relationships Research Research Research

Research

Research Research Program ROSE Member Member

BioMelbourne Network. Member

Union for International Cancer Control, UICC Member

Prince of Wales Hospital, NSW Australian Cervical Cancer Typing Study

Royal Brisbane Hospital, Brisbane, QLD Mercy Hospital for Women/Austin Pathology, VIC

Australian Cervical Cancer Typing Study Australian Cervical Cancer Typing Study Westmead Hospital, NSW Australian Cervical Cancer Typing Study Royal Prince Alfred Hospital and Chris O’Brien Lifehouse, NSW Australian Cervical Cancer Typing Study Royal Women’s Hospital, VIC Australian Cervical Cancer Typing Study Pathology North, NSW Australian Cervical Cancer Typing Study

Monash University, VIC Research relating to Multiple Sclerosis treatments and cervical HSIL/cancer risk

Notre Dame University, WA Burnet Institute Research Research

McGill University, Canada International Agency for Research on Cancer Baker Heart and Diabetes Institute Christian Medical College Vellore, India Zoram Medical College, Mizoram, India RMI International Research Global Alliance for Chronic Diseases project Global Alliance for Chronic Diseases project Global Alliance for Chronic Diseases project Global Alliance for Chronic Diseases project Global Alliance for Chronic Diseases project

VCS FOUNDATION PUBLISHED ARTICLES 2020/21

AUTHORS Brotherton JML, Wheeler C, Clifford G, Elfstrom M, Saville M, Kaldor J, Machalek DA.

Cornall A , Saville M, Pyman J, Callegari E, Tan F, Brotherton J, Malloy M, Tabrizi S, Wrede C.D, Garland S. Vaccine HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.

JOURNAL TITLE Preventive Medicine Surveillance systems for monitoring cervical cancer elimination efforts: focus on HPV infection, cervical dysplasia, cervical screening and treatment. REFERENCE Prev Med. 2020 Oct 16:106293. doi: 10.1016/j. ypmed.2020.106293.

Vaccine 2020 Sep 11;38(40):6304-6311. https://doi: 10.1016/j. vaccine.2020.07.037.

Cornall A, Brotherton J., Callegari E, Tan F, Saville M, Pyman J, Phillips Sl, Malloy M., Tabrizi S, Garland S., on behalf of the VACCINE study group. Vaccine Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixedgenotype biopsy specimens using laser capture microdissection as the reference standard.

Dodd RH, Nickel B, Smith MA, Brotherton JML, McCaffery KJ.

Martellucci CA, Nomura S, Yoneoka D, Ueda P, Brotherton JML, Canfell K, Palmer M, Manzoli L, Rossi PG, De Togni A, Palmonar C, Califano A, Saito E, Hashizume M, Shibuya K. BJOG Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study.

Phillips A, Hickie M, Totterdell J, Brotherton J, Dey A, Hill R, Snelling T, Macartney K. Vaccine Adverse events following HPV vaccination: 11 years of surveillance in Australia.

Preventive Medicine Getting the timing right: women’s views on the best time to announce changes to cancer screening policy recommendations.

Ross J, Greaves J, Saville M, Earls , Pagliuso J. Pathology Performance measures for Australian laboratories reporting cervical cytology 2009–2017: the impact of the national HPV vaccination program.

Smith M, Saville M, Canfell K. Medical Journal of Australia HPV swab self-collection and cervical cancer in women who have sex with women.

Stolnicu S, Talia KL, McCluggage WG. Advances in Anatomic Pathology The Evolving Spectrum of Precursor Lesions of Cervical Adenocarcinomas.

Subasinghe AK, Wark JD, Phillips S, Cornall A, Brotherton JML, Garland SM. Sexual Health The quadrivalent human papillomavirus vaccination is successful in reducing the prevalence of vaccine-targeted genotypes in a young vaccine- eligible age sample of Australian females.

Sultana F, Roeske L, Malloy MJ, McDermott TL, Saville M, Brotherton JML. PLoS ONE Implementation of Australia’s Renewed Cervical Screening Program: Preparedness of General Practitioners and Nurses. Vaccine 2020;38(40): 6312–6319. https:// doi.org/10.1016/j. vaccine.2020.07.036

Preventive Medicine Reports 2020;20:101268. https://doi.org/10.1016/j. pmedr.2020.101268 BJOG 2021 Feb;128(3):532539. doi: 10.1111/14710528.16429. Epub 2020 Aug 10.

Vaccine. 2020;S0264410X(20)30825-2. doi:10.1016/j. vaccine.2020.06.039 Pathology 2020 52(5):522528

Med. J. Aust., 213: 239-239. e1, 7th September 2020

Advances in Anatomic Pathology. 2020 Sep;27(5):278293. DOI: 10.1097/ pap.0000000000000266. Sexual Health 2020; 17(6) https://doi.org/10.1071/ SH20033

PLoS ONE 2020;15(1):e0228042. https:// doi.org/10.1371/journal. pone.0228042.

VCS FOUNDATION PUBLISHED ARTICLES 2020/21

AUTHORS Tan J, Jayasinghe Y, Osinski M, Brotherton JML, Wrede CDH.

Teutsch SM, Nunez CA, Morris A, McGregor S, King J, Brotherton JML, Novakovic D, Booy R, Jones CA, Rawlinson W, Thorley BR, Elliot EJ. Commun Dis Intell. Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019.

Wong RW, Richard Wing-Cheuk, Talia KL, McCluggage WG. The American Journal of Surgical Pathology Endometrial Gastric-type Carcinoma: An Aggressive and Morphologically Heterogenous New Histotype Arising From Gastric Metaplasia of the Endometrium.

Yeasmeen T, Kelaher M, Brotherton JML, Malloy MJ.

Atchison-Wright S, Shilling H, Balgovind P, Machalek D, Hawkes D, Garland S, Saville M, Murray G, Molano M, Danielewski J, Phillips S. Journal of Applied Microbiology Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay.

Brotherton J, Machalek D, Smith M, Yuill S, Sherrah Whop L , Evans S, Bateson D, Marshall H, Garland S, Hawkes D, Wrede D, Guy R, Nightingale C, Kaldor J, Saville M and Canfell K. Creagh NS, Zammit C, Brotherton JM, Saville M, McDermott T, Nightingale C, Kelaher M.

Davies C, Stoney T, Hutton H, Parrella A, Kang A, Macartney K, Leask J, McCaffrey K, Zimet G, Brotherton J, Marshall HS, Skinner SR, for the HPV.edu Study Group Vaccine School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination.

Jaenke R, Butler TL, Condon J, Garvey G, Brotherton JML, Cunningham J, Anderson K, Tong A, Moore SP, Whop LJ. Aust N Z Journal of Public Health Health care provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study.

JOURNAL TITLE Aust N Z J Obstet Gynaecol Recurrent Post Coital Bleeding: Should colposcopy still be mandatory?

PLoS One. Understanding the participation of breast screening among women born in predominantly Muslim countries living in Victoria, Australia from record-linkage data.

2021 Cervical Cancer Elimination Progress Report Australia’s progress towards the elimination of cervical cancer as a public health problem. NHMRC Centre of Research Excellence in Cervical Cancer Control.

Medical Journal of Australia Self-collection cervical screening in the renewed National Cervical Screening Program: a qualitative study. REFERENCE Aust N Z J Obstet Gynaecol 2020; 1–8. DOI: 10.1111/ ajo.13247 Commun Dis Intell. 2020;44 (https://doi.org/10.33321/ cdi.2020.44.60) Epub 17/8/2020 Am J Surg Pathol. 2020 Dec;44(12):17361737. doi: 10.1097/ PAS.0000000000001473.

PLoS One. 2020;15(8):e0237341. Published 2020 Aug 7. doi:10.1371/journal. pone.0237341 J Appl Microbiol. 2021 May 3. doi: 10.1111/jam.15126

https://www. cervicalcancercontrol.org.au

Med J Aust. 2021 Oct 18;215(8):354-358. doi: 10.5694/mja2.51137. Epub 2021 Jun 18. Vaccine. 2021 Jul 5;39(30):4190-4198. doi: 10.1016/j.vaccine.2021.05.051. Epub 2021 Jun 12.

Aust N Z J Public Health. 2021 Apr;45(2):150-157. doi: 10.1111/1753-6405.13084

Nesbitt C, Rath L, Cheng AC, Butzkueven H, Wesselingh R, Skibina O, Monif M, Yeh WZ, Brotherton JML, Reddel S, Van der Walt A. Medical Journal of Australia Vaccinations in patients with multiple sclerosis: review and recommendations. Med J Aust. 2021 May;214(8):350-354.e1. doi: 10.5694/mja2.51012. Epub 2021 Apr 18.

AUTHORS Ng H YK, Tan JHJ, Marceglia AH, Bittinger S, Dundas K, Talia K, Wrede C.H.

Obermair HM, Bennett K, Brotherton JML, Smith MA, McCaffery KJ, Dodd RH. ANZJOG Australian National Cervical Screening Program Renewal: attitudes and experiences of General Practitioners, and Obstetricians and Gynaecologists.

Palmer M, Katanoda K, Saito E, Martellucci C, Nomura Z, Ota E, Brotherton JML, Hocking J. Systematic Reviews National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis protocol.

Selenica P, Alemar B, Matrai C, Talia KL, Veras E, Hussein Y, Oliva E, BeetsTan RGH, Mikami Y, McCluggage WG, Kiyokawa T, Weigelt B, Park KJ, Murali R. Modern Pathology Massively Parallel Sequencing Analysis of 71 Gastric-Type Cervical Adenocarcinomas Reveals Mutations in Cell Cycle-Related Genes and Rare Potentially Targetable ERBB2 Mutations.

Smith M, Hall M, Saville M, Brotherton J, Simms K, Lew J-B, Bateson D, Skinner SR, Kelaher M, Canfell K. JOURNAL TITLE ANZJOG Outcomes of women with positive oncogenic HPV and reflex cytology showing possible high-grade squamous intraepithelial lesion.

Cancer Epidemiol Biomarkers Prev. Could HPV testing on self-collected samples be routinely used in an organised cervical screening program? A modelled analysis.

Smith MA, Winch K, Canfell K, Brotherton JM. Tumour Virus Research Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: what if one or two doses are sufficient?

Talia KL, Arora R, McCluggage WG. International Journal of Gynecological Pathology Precursor Lesions of Cervical Clear Cell Carcinoma: Evidence For Origin From Tubo-Endometrial Metaplasia.

Talia KL, Naaman Y, McCluggage WG. International Journal of Gynecological Pathology Uterine Adenosarcoma Originating in Adenomyosis: Report of an Extremely Rare Phenomenon and Review of Published Literature.

Talia KL, Oliva E, Rabban JT, Singh N, Stolnicu S, McCluggage WG. International Journal of Gynecological Pathology Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists.

Talia KL, Parra-Herran C, McCluggage WG. Histopathology Ovarian Mucinous and Seromucinous Neoplasms: Problematic Aspects and Modern Diagnostic Approach.

Woo YL, Gravitt P, Kheng KS, Ng CW, Saville M. Preventative Medicine Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era. REFERENCE Aust N Z J Obstet Gynaecol https://doi.org/10.1111/ ajo.13408

Aust N Z J Obstet Gynaecol. 2021 Jun;61(3):416-423. doi: 10.1111/ajo.13310. Epub 2021 Jan 29.

Syst Rev 2021;10: 135. https://doi.org/10.1186/ s13643-021-01686-6

Modern Pathology 2021: 34:1213-1225.

Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):268-277. doi: 10.1158/1055-9965.EPI-200998. Epub 2020 Nov 20. Tumour Virus Res. 2021 Apr 14:200216. doi: 10.1016/j. tvr.2021.200216. Epub ahead of print Int J Gynecol Pathol. 2021 Mar 24. doi: 10.1097/ PGP.0000000000000785. Epub ahead of print. Int J Gynecol Pathol 2021 Jul 1;40(4):342348. doi: 10.1097/ PGP.0000000000000709. Int J Gynecol Pathol. 2021 Mar 1;40(Suppl 1):S66-S74. doi: 10.1097/ PGP.0000000000000741.

Histopathology. 2021 May 7. doi: 10.1111/his.14399. Online ahead of print. Prev Med. 2021 Mar;144:106294. doi: 10.1016/j.ypmed.2020.106294. Epub 2021 Mar 4.